Your browser doesn't support javascript.
loading
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.
Chen, Brian; Nagai, Sumimasa; Armitage, James O; Witherspoon, Bartlett; Nabhan, Chadi; Godwin, Ashley C; Yang, Y Tony; Kommalapati, Anuhya; Tella, Sri Harsha; DeAngelis, Carlo; Raisch, Dennis W; Sartor, Oliver; Hrushesky, William J; Ray, Paul S; Yarnold, Paul R; Love, Bryan L; Norris, LeAnn B; Knopf, Kevin; Bobolts, Laura; Riente, Joshua; Luminari, Stefano; Kane, Robert C; Hoque, Shamia; Bennett, Charles L.
Afiliación
  • Chen B; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.
  • Nagai S; Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.
  • Armitage JO; William Jennings Bryan Dorn VA Medical Center, Columbia, South Carolina, USA.
  • Witherspoon B; Translational Research Center, The University of Tokyo Hospital, Tokyo, Japan.
  • Nabhan C; University of Nebraska School of Medicine, Omaha, Nebraska, USA.
  • Godwin AC; College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Yang YT; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.
  • Kommalapati A; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.
  • Tella SH; Center for Health Policy and Media Engagement, George Washington University, Washington, D.C., USA.
  • DeAngelis C; School of Medicine, University of South Carolina, Columbia, South Carolina, USA.
  • Raisch DW; School of Medicine, University of South Carolina, Columbia, South Carolina, USA.
  • Sartor O; Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.
  • Hrushesky WJ; College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA.
  • Ray PS; Tulane University School of Medicine, New Orleans, Louisiana, USA.
  • Yarnold PR; Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.
  • Love BL; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Norris LB; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.
  • Knopf K; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.
  • Bobolts L; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.
  • Riente J; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.
  • Luminari S; South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia, South Carolina, USA.
  • Kane RC; Alameda Health System, Oakland, California, USA.
  • Hoque S; Oncology Analytics Inc., Plantation, Florida, USA.
  • Bennett CL; Nova Southeastern University College of Pharmacy, Fort Lauderdale, Florida, USA.
Oncologist ; 24(4): 537-548, 2019 04.
Article en En | MEDLINE | ID: mdl-30842244
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Costos de los Medicamentos / Ahorro de Costo / Industria Farmacéutica / Biosimilares Farmacéuticos / Filgrastim / Neutropenia / Antineoplásicos Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Humans País/Región como asunto: America do norte / Asia / Europa Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Costos de los Medicamentos / Ahorro de Costo / Industria Farmacéutica / Biosimilares Farmacéuticos / Filgrastim / Neutropenia / Antineoplásicos Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Humans País/Región como asunto: America do norte / Asia / Europa Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos